Solana Co — Director's Dealing 2020

Jun 16, 2020

SEC Form 3/A — Form 3/A

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2020-06-10

Reporting Person: MATHIESEN JEFFREY S (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (Right to Buy)	$0.545	2030-06-09	Class A Common Stock (61218)		Direct

Footnotes

F1: Grant to the Reporting Person of a stock option under the Issuer's 2018 Omnibus Incentive Plan. The shares vest in a series of twelve (12) successive equal monthly installments measured from June 10, 2020, subject to the Reporting Person's continued service through each applicable vesting date.

F2: This Form 3/A is being filed to amend an inadvertent error in the number of stock options granted to the Reporting Person in the Form 3 previously filed on June 12, 2020. The number of stock options reported on this amendment reflect the correct number of stock options granted to the Reporting Person.